41230 - Idiopathic Pulmonary Fibrosis (Answered)

Mark Menzies
To ask the Secretary of State for Health, how much his Department has spent on funding research into improving the treatment of idiopathic pulmonary fibrosis.

George Freeman

The information requested is not available.

The Department’s National Institute for Health Research (NIHR) spent £25.5 million on respiratory disease research in 2014/15 (the latest available figure). Most of this investment (£16.6 million in 2014/15) is in infrastructure for respiratory research where spend on specific topics such as the treatment of idiopathic pulmonary fibrosis cannot be separated from total infrastructure expenditure. This infrastructure includes NIHR biomedical research centres and the NIHR Clinical Research Network.

The NIHR manages the Efficacy and Mechanism Evaluation programme, which is funded by the Medical Research Council and NIHR. The programme is currently funding a £1.4 million efficacy and mechanism evaluation of treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole.